| Name | Title | Contact Details |
|---|
Juvly Aesthetics is the fastest growing aesthetics practice in the United States, expanding since 2014, from a single location in Columbus, Ohio to eleven locations across the United States! Our team has gone from servicing just 10 clients to over 53,000 in five short years! The core of this growth stems from our unique values, which include; providing fantastic, natural-beauty enhancing results, transparent prices, and excellent customer service. Whether you are a client looking for first class services, or an eager employment-seeker, Juvly is the place for you!
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
National Surgical Adjuvant Breast and Bowel is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sigvaris Inc is a Peachtree City, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Boys Town National Research Hospital is a Omaha, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.